Gonal-f RFF Redi-ject is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Emd Serono, Inc.. The primary component is Follitropin.
Product ID | 44087-1117_2e6b585c-986b-4838-a7fa-326b34b5c146 |
NDC | 44087-1117 |
Product Type | Human Prescription Drug |
Proprietary Name | Gonal-f RFF Redi-ject |
Generic Name | Follitropin |
Dosage Form | Injection, Solution |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2013-10-16 |
Marketing Category | NDA / NDA |
Application Number | NDA021684 |
Labeler Name | EMD Serono, Inc. |
Substance Name | FOLLITROPIN |
Active Ingredient Strength | 900 [iU]/1.5mL |
Pharm Classes | Gonadotropin [EPC],Gonadotropins [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2013-10-16 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA021684 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2013-10-16 |
Marketing Category | BLA |
Application Number | BLA021684 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2013-10-16 |
Marketing End Date | 2014-08-25 |
Ingredient | Strength |
---|---|
FOLLITROPIN | 900 [iU]/1.5mL |
SPL SET ID: | b6d11c45-b502-478e-bb28-2ff596ea259c |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
44087-1115 | Gonal-f RFF Redi-ject | FOLLITROPIN |
44087-1116 | Gonal-f RFF Redi-ject | FOLLITROPIN |
44087-1117 | Gonal-f RFF Redi-ject | FOLLITROPIN |
44087-1118 | Gonal-f RFF Redi-ject | FOLLITROPIN |
0052-0313 | Follistim AQ | follitropin |
0052-0316 | Follistim AQ | follitropin |
0052-0326 | Follistim AQ | follitropin |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
GONAL-F RFF REDI-JECT 86110018 4689651 Live/Registered |
Merck KGaA 2013-11-04 |